TY - JOUR
T1 - Language impairment in the genetic forms of behavioural variant frontotemporal dementia
AU - Samra, Kiran
AU - MacDougall, Amy M.
AU - Bouzigues, Arabella
AU - Bocchetta, Martina
AU - Cash, David M.
AU - Greaves, Caroline V.
AU - Convery, Rhian S.
AU - van Swieten, John C.
AU - Seelaar, Harro
AU - Jiskoot, Lize
AU - Moreno, Fermin
AU - Sanchez-Valle, Raquel
AU - Laforce, Robert
AU - Graff, Caroline
AU - Masellis, Mario
AU - Tartaglia, Maria Carmela
AU - Rowe, James B.
AU - Borroni, Barbara
AU - Finger, Elizabeth
AU - Synofzik, Matthis
AU - Galimberti, Daniela
AU - Vandenberghe, Rik
AU - de Mendonça, Alexandre
AU - Butler, Christopher R.
AU - Gerhard, Alexander
AU - Ducharme, Simon
AU - le Ber, Isabelle
AU - Tiraboschi, Pietro
AU - Santana, Isabel
AU - Pasquier, Florence
AU - Levin, Johannes
AU - Otto, Markus
AU - Sorbi, Sandro
AU - Rohrer, Jonathan D.
AU - Russell, Lucy L.
AU - on behalf of the Genetic FTD Initiative (GENFI)
AU - Nelson, Annabel
AU - Thomas, David L.
AU - Todd, Emily
AU - Benotmane, Hanya
AU - Nicholas, Jennifer
AU - Shafei, Rachelle
AU - Timberlake, Carolyn
AU - Cope, Thomas
AU - Rittman, Timothy
AU - Benussi, Alberto
AU - Premi, Enrico
AU - Gasparotti, Roberto
AU - Archetti, Silvana
AU - Gazzina, Stefano
AU - Cantoni, Valentina
AU - Arighi, Andrea
AU - Fenoglio, Chiara
AU - Scarpini, Elio
AU - Fumagalli, Giorgio
AU - Borracci, Vittoria
AU - Rossi, Giacomina
AU - Giaccone, Giorgio
AU - di Fede, Giuseppe
AU - Caroppo, Paola
AU - Prioni, Sara
AU - Redaelli, Veronica
AU - Tang-Wai, David
AU - Rogaeva, Ekaterina
AU - Castelo-Branco, Miguel
AU - Freedman, Morris
AU - Keren, Ron
AU - Black, Sandra
AU - Mitchell, Sara
AU - Shoesmith, Christen
AU - Bartha, Robart
AU - Rademakers, Rosa
AU - Poos, Jackie
AU - Papma, Janne M.
AU - Giannini, Lucia
AU - van Minkelen, Rick
AU - Pijnenburg, Yolande
AU - Nacmias, Benedetta
AU - Ferrari, Camilla
AU - Polito, Cristina
AU - Lombardi, Gemma
AU - Bessi, Valentina
AU - Veldsman, Michele
AU - Andersson, Christin
AU - Thonberg, Hakan
AU - Öijerstedt, Linn
AU - Jelic, Vesna
AU - Thompson, Paul
AU - Langheinrich, Tobias
AU - Lladó, Albert
AU - Antonell, Anna
AU - Olives, Jaume
AU - Balasa, Mircea
AU - Bargalló, Nuria
AU - Borrego-Ecija, Sergi
AU - Verdelho, Ana
AU - Maruta, Carolina
AU - Ferreira, Catarina B.
AU - Miltenberger, Gabriel
AU - do Couto, Frederico Simões
AU - Gabilondo, Alazne
AU - Gorostidi, Ana
AU - Villanua, Jorge
AU - Cañada, Marta
AU - Tainta, Mikel
AU - Zulaica, Miren
AU - Barandiaran, Myriam
AU - Alves, Patricia
AU - Bender, Benjamin
AU - Wilke, Carlo
AU - Graf, Lisa
AU - Vogels, Annick
AU - Vandenbulcke, Mathieu
AU - van Damme, Philip
AU - Bruffaerts, Rose
AU - Poesen, Koen
AU - Rosa-Neto, Pedro
AU - Gauthier, Serge
AU - Camuzat, Agnès
AU - Brice, Alexis
AU - Bertrand, Anne
AU - Funkiewiez, Aurélie
AU - Rinaldi, Daisy
AU - Saracino, Dario
AU - Colliot, Olivier
AU - Sayah, Sabrina
AU - Prix, Catharina
AU - Wlasich, Elisabeth
AU - Wagemann, Olivia
AU - Loosli, Sandra
AU - Schönecker, Sonja
AU - Hoegen, Tobias
AU - Lombardi, Jolina
AU - Anderl-Straub, Sarah
AU - Rollin, Adeline
AU - Kuchcinski, Gregory
AU - Bertoux, Maxime
AU - Lebouvier, Thibaud
AU - Deramecourt, Vincent
AU - Santiago, Beatriz
AU - Duro, Diana
AU - Leitão, Maria João
AU - Almeida, Maria Rosario
AU - Tábuas-Pereira, Miguel
AU - Afonso, S. nia
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2023/4/1
Y1 - 2023/4/1
N2 - Background: Behavioural variant fronto-temporal dementia (bvFTD) is characterised by a progressive change in personality in association with atrophy of the frontal and temporal lobes. Whilst language impairment has been described in people with bvFTD, little is currently known about the extent or type of linguistic difficulties that occur, particularly in the genetic forms. Methods: Participants with genetic bvFTD along with healthy controls were recruited from the international multicentre Genetic FTD Initiative (GENFI). Linguistic symptoms were assessed using items from the Progressive Aphasia Severity Scale (PASS). Additionally, participants undertook the Boston Naming Test (BNT), modified Camel and Cactus Test (mCCT) and a category fluency test. Participants underwent a 3T volumetric T1-weighted MRI, with language network regional brain volumes measured and compared between the genetic groups and controls. Results: 76% of the genetic bvFTD cohort had impairment in at least one language symptom: 83% C9orf72, 80% MAPT and 56% GRN mutation carriers. All three genetic groups had significantly impaired functional communication, decreased fluency, and impaired sentence comprehension. C9orf72 mutation carriers also had significantly impaired articulation and word retrieval as well as dysgraphia whilst the MAPT mutation group also had impaired word retrieval and single word comprehension. All three groups had difficulties with naming, semantic knowledge and verbal fluency. Atrophy in key left perisylvian language regions differed between the groups, with generalised involvement in the C9orf72 group and more focal temporal and insula involvement in the other groups. Correlates of language symptoms and test scores also differed between the groups. Conclusions: Language deficits exist in a substantial proportion of people with familial bvFTD across all three genetic groups. Significant atrophy is seen in the dominant perisylvian language areas and correlates with language impairments within each of the genetic groups. Improved understanding of the language phenotype in the main genetic bvFTD subtypes will be helpful in future studies, particularly in clinical trials where accurate stratification and monitoring of disease progression is required.
AB - Background: Behavioural variant fronto-temporal dementia (bvFTD) is characterised by a progressive change in personality in association with atrophy of the frontal and temporal lobes. Whilst language impairment has been described in people with bvFTD, little is currently known about the extent or type of linguistic difficulties that occur, particularly in the genetic forms. Methods: Participants with genetic bvFTD along with healthy controls were recruited from the international multicentre Genetic FTD Initiative (GENFI). Linguistic symptoms were assessed using items from the Progressive Aphasia Severity Scale (PASS). Additionally, participants undertook the Boston Naming Test (BNT), modified Camel and Cactus Test (mCCT) and a category fluency test. Participants underwent a 3T volumetric T1-weighted MRI, with language network regional brain volumes measured and compared between the genetic groups and controls. Results: 76% of the genetic bvFTD cohort had impairment in at least one language symptom: 83% C9orf72, 80% MAPT and 56% GRN mutation carriers. All three genetic groups had significantly impaired functional communication, decreased fluency, and impaired sentence comprehension. C9orf72 mutation carriers also had significantly impaired articulation and word retrieval as well as dysgraphia whilst the MAPT mutation group also had impaired word retrieval and single word comprehension. All three groups had difficulties with naming, semantic knowledge and verbal fluency. Atrophy in key left perisylvian language regions differed between the groups, with generalised involvement in the C9orf72 group and more focal temporal and insula involvement in the other groups. Correlates of language symptoms and test scores also differed between the groups. Conclusions: Language deficits exist in a substantial proportion of people with familial bvFTD across all three genetic groups. Significant atrophy is seen in the dominant perisylvian language areas and correlates with language impairments within each of the genetic groups. Improved understanding of the language phenotype in the main genetic bvFTD subtypes will be helpful in future studies, particularly in clinical trials where accurate stratification and monitoring of disease progression is required.
KW - C9orf72
KW - Frontotemporal dementia
KW - Genetics
KW - Language
KW - Progranulin
KW - Tau
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150489497&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36538154
U2 - 10.1007/s00415-022-11512-1
DO - 10.1007/s00415-022-11512-1
M3 - Article
C2 - 36538154
SN - 0340-5354
VL - 270
SP - 1976
EP - 1988
JO - Journal of Neurology
JF - Journal of Neurology
IS - 4
ER -